Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Yacon on Platelet Function in Hypercholesterolemic Rabbits

  • Lim, Yong (Department of Clinical Laboratory Science, Dong-eui Univerisity) ;
  • Son, Dong-Ju (College of Pharmacy, Chungbuk National University) ;
  • Kim, Yun-Bae (Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Hwang, Bang-Yeon (College of Pharmacy, Chungbuk National University) ;
  • Yun, Yeo-Pyo (College of Pharmacy, Chungbuk National University) ;
  • Hwang, Seock-Yeon (Department of Biomedical Laboratory Science, Daejeon University)
  • Received : 2011.04.29
  • Accepted : 2011.09.08
  • Published : 2011.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Hypercholesterolemia indirectly increases the risk of arterial and venous thrombosis by enhancing the ability of platelets to aggregate. Yacon (Smallanthus sonchifolius) is composed of fructooligosaccharides, proteins, minerals and phenolic compounds, and has potential benefits for the management of diabetes. This study investigated whether the consumption of yacon in the diet inhibits platelet aggregation under hypercholesterolemic conditions. Male New Zealand white rabbits were fed one of five dietary interventions: a normal control diet, 0.5% cholesterol diet, 0.5% cholesterol diet+a low dose of yacon (0.5 g/kg body weight given orally each day), 0.5% cholesterol diet+a high dose of yacon (2.5 g/kg body weight given orally each day), or a 0.5% cholesterol diet+lovastatin (2 mg/kg body weight given orally each day). After 8 weeks, blood was collected to measure the amount of collagen- and thrombin-induced platelets present. Yacon inhibited the platelet aggregation induced by low doses of agonists (0.5 ${\mu}g/mL$ collagen and 0.02 units/ml thrombin) in a concentration-dependent manner. In addition, yacon concentration-dependently inhibited collagen-induced arachidonic acid liberation. Moreover, n-hexane, chloroform and ethyl acetate fractions showed a marked and selective inhibition of the platelet aggregation induced by collagen, again in a dose-dependent manner. These fractions, especially that of chloroform, significantly suppressed platelet aggregation. The results of this study demonstrate that when yacon is added to a cholesterol-enriched diet, cholesterol-induced platelet aggregation returns to control levels. This may also be beneficial in preventing atherosclerosis and reducing risk factors for coronary artery disease and stroke.

Keywords

References

  1. Bocan, T. M., Schifani, T. A. and Guyton, J. R. (1986) Ultrastructure of the human aortic fibrolipid lesion. Formation of the atherosclerotic lipid-rich core. Am. J. Pathol. 123, 413-424.
  2. Bodin, S., Giuriato, S., Ragab, J., Humbel, B. M., Viala, C., Vieu, C., Chap, H. and Payrastre, B. (2001) Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry 40, 15290-15299. https://doi.org/10.1021/bi0109313
  3. Fernandez-Ortiz, A., Badimon, J. J., Falk, E., Fuster, V., Meyer, B., Mailhac, A., Weng, D., Shah, P. K. and Badimon, L. (1994) Characterization of the relative thrombogenicity of atherosclerotic plaque components: implications for consequences of plaque rupture. J. Am. Coll. Cardiol. 23, 1562-1569. https://doi.org/10.1016/0735-1097(94)90657-2
  4. Fuster, V., Badimon, L., Badimon, J. J. and Chesebro, J. H. (1992) The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 326, 242-250. https://doi.org/10.1056/NEJM199201233260406
  5. Grgurevich, S., Krishnan, R., White, M. M. and Jennings, L. K. (2003) Role of in vitro cholesterol depletion in mediating human platelet aggregation. J. Thromb. Haemost. 1, 576-586. https://doi.org/10.1046/j.1538-7836.2003.00087.x
  6. Hashizume, T., Nakao, M., Kageura, T. and Sato, T. (1997) Sphingosine enhances arachidonic acid liberation in response to U46619 through an increase in phospholipase A2 activity in rabbit platelets. J. Biochem. 122, 1034-1039. https://doi.org/10.1093/oxfordjournals.jbchem.a021843
  7. Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. and Collen, D. (1998) Oxidized LDL and malondialdehyde-modifi ed LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98, 1487-1494. https://doi.org/10.1161/01.CIR.98.15.1487
  8. Hwang, S. Y., Son, D. J., Kim, I. W., Kim, D. M., Sohn, S. H., Lee, J. J. and Kim, S. K. (2008) Korean red ginseng attenuates hypercholesterolemia- enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Phytother. Res. 22, 778-783. https://doi.org/10.1002/ptr.2363
  9. Kovanen, P. T. and Pentikainen, M. O. (2003) Circulating lipoproteins as proinfl ammatory and anti-infl ammatory particles in atherogenesis. Curr. Opin. Lipidol. 14, 411-419. https://doi.org/10.1097/00041433-200310000-00001
  10. Kramer, R. M., Jakubowski, J. A., Vaillancourt, R. and Deykin, D. (1982) Effect of membrane cholesterol on phospholipid metabolism in thrombin-stimulated platelets. Enhanced activation of platelet phospholipase(s) for liberation of arachidonic acid. J. Biol. Chem. 257, 6844-6849.
  11. Nosal, R. and Jancinova, V. (2001) Pharmacological intervention with platelet phospholipase A2. Bratisl. Lek. Listy 102, 447-453.
  12. Notarbartolo, A., Davi, G., Averna, M., Barbagallo, C. M., Ganci, A., Giammarresi, C., La Placa, F. P. and Patrono, C. (1995) Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 15, 247-251. https://doi.org/10.1161/01.ATV.15.2.247
  13. Park, J. S., Yang, J. S., Hwang, B. Y., Yoo, B. K. and Han, K. (2009) Hypoglycemic effect of yacon tuber extract and its constituent, chlorogenic acid, in streptozotocin-induced diabetic rats. Biomol. Ther. 17, 256-262. https://doi.org/10.4062/biomolther.2009.17.3.256
  14. Patrono, C., Falco, A. and Davi, G. (2005) Isoprostane formation and inhibition in atherothrombosis. Curr. Opin. Pharmacol. 5, 198-203. https://doi.org/10.1016/j.coph.2004.11.003
  15. Quinton, T. M., Kim, S., Jin, J. and Kunapuli, S. P. (2005) Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. J. Thromb. Haemost. 3, 1036-1041. https://doi.org/10.1111/j.1538-7836.2005.01325.x
  16. Sanchez-Quesada, J. L., Benitez, S. and Ordonez-Llanos, J. (2004) Electronegative low-density lipoprotein. Curr. Opin. Lipidol. 15, 329-335. https://doi.org/10.1097/00041433-200406000-00014
  17. Sevanian, A., Bittolo-Bon, G., Cazzolato, G., Hodis, H., Hwang, J., Zamburlini, A., Maiorino, M. and Ursini, F. (1997) LDL- is a lipid hydroperoxide-enriched circulating lipoprotein. J. Lipid. Res. 38, 419-428.
  18. Sevanian, A., Hwang, J., Hodis, H., Cazzolato, G., Avogaro, P. and Bittolo-Bon, G. (1996) Contribution of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations. Arterioscler. Thromb. Vasc. Biol. 16, 784-793. https://doi.org/10.1161/01.ATV.16.6.784
  19. Shattil, S. J., Anaya-Galindo, R., Bennett, J., Colman, R. W. and Cooper, R. A. (1975) Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55, 636-643. https://doi.org/10.1172/JCI107971
  20. Tanaga, K., Bujo, H., Inoue, M., Mikami, K., Kotani, K., Takahashi, K., Kanno, T. and Saito, Y. (2002) Increased circulating malondialdehyde- modifi ed LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler. Thromb. Vasc. Biol. 22, 662-666. https://doi.org/10.1161/01.ATV.0000012351.63938.84
  21. van Lier, M., Verhoef, S., Cauwenberghs, S., Heemskerk, J. W., Akkerman, J. W. and Heijnen, H. F. (2008) Role of membrane cholesterol in platelet calcium signalling in response to VWF and collagen under stasis and flow. Thromb. Haemost. 99, 1068-1078.
  22. Watala, C. (2005) Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Curr. Pharm. Des. 11, 2331-2365. https://doi.org/10.2174/1381612054367337
  23. Willoughby, S., Holmes, A. and Loscalzo, J. (2002) Platelets and cardiovascular disease. Eur. J. Cardiovasc. Nurs. 1, 273-288. https://doi.org/10.1016/S1474-5151(02)00038-5
  24. Yabuta, G., Koizumi, Y., Namiki, K., Hida, M. and Namiki, M. (2001) Structure of green pigment formed by the reaction of caffeic acid esters (or chlorogenic acid) with a primary amino compound. Biosci. Biotechnol. Biochem. 65, 2121-2130. https://doi.org/10.1271/bbb.65.2121
  25. Yan, X., Suzuki, M., Ohnishi-Kameyama, M., Sada, Y., Nakanishi, T. and Nagata, T. (1999) Extraction and identifi cation of antioxidants in the roots of yacon (Smallanthus sonchifolius). J. Agric. Food. Chem. 47, 4711-4713. https://doi.org/10.1021/jf981305o